TRxADE HEALTH
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-24.28-30.98-5.2449.761.16K-95.50-15.88-4.66-0.79-0.22-0.41-0.41
Price/Sales ratio
32.656.935.834.902.735.262.381.940.290.482.992.73
Price/Book Value ratio
73.10129.63-12.60-46.0912.419.454.695.094.477.320.909.45
Price/Cash Flow ratio
-45.89-28.79-11.0283.7638.36276.01-18.40-7.48-2.23-1.91-1.43276.01
Price/Free Cash Flow ratio
-45.89-28.79-11.0283.7640.58657.42-18.09-7.41-1.72-1.91-1.81657.42
Price/Earnings Growth ratio
0.450.62-0.03-0.45-11.940.02-0.04-0.08-1.2-0.00-0.02-11.94
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A230.56%N/A
Profitability Indicator Ratios
Gross Profit Margin
70.58%61.37%99.34%100%88.28%65.50%33.33%47.99%47.61%31.40%-12.48%65.50%
Operating Profit Margin
-95.67%-19.77%-39.64%13.47%-2.28%7.60%-10.39%-53.51%-24.07%-87.80%-316.76%7.60%
Pretax Profit Margin
-134.47%-22.37%-47.26%9.85%0.23%-3.82%-14.81%-53.75%-34.15%-165.86%-454.92%-3.82%
Net Profit Margin
-134.47%-22.37%-111.21%9.85%0.23%-5.50%-14.98%-41.59%-37.64%-215.70%-576.06%-5.50%
Effective Tax Rate
-28.64%-11.64%-138.48%-17.62%-1706.07%-44.05%-1.15%22.62%-10.23%-38.89%-31.44%-1706.07%
Return on Assets
-164.63%-55.09%-818.72%46.80%0.40%-7.35%-26.19%-71.33%-116.17%-142.37%-171.83%-7.35%
Return On Equity
-301.00%-418.39%240.41%-92.64%1.06%-9.89%-29.55%-109.09%-564.80%-3290.02%-272.11%-9.89%
Return on Capital Employed
-214.15%-101.19%86.51%428.89%-6.40%11.20%-19.89%-109.34%-176.33%-743.77%-117.44%11.20%
Liquidity Ratios
Current Ratio
2.201.150.221.151.707.3010.94N/AN/AN/A4.161.70
Quick Ratio
2.111.650.210.961.617.199.454.660.910.234.151.61
Cash ratio
1.270.810.000.351.015.517.023.370.520.012.661.01
Days of Sales Outstanding
85.1425.9343.9839.7741.3038.8740.3436.1320.08109.97292.0441.30
Days of Inventory outstanding
38.5153.89500.54N/A64.998.0740.213.997.270.060.478.07
Operating Cycle
123.6579.83544.53N/A106.3046.9580.5640.1227.36110.03292.51106.30
Days of Payables Outstanding
241.4241.715.28KN/A325.5747.608.2133.8532.13133.9353.2053.20
Cash Conversion Cycle
-117.7638.12-4.73KN/A-219.26-0.6572.356.27-4.77-23.89239.31-219.26
Debt Ratios
Debt Ratio
N/A0.542.311.070.370.170.060.210.420.56N/A0.17
Debt Equity Ratio
N/A4.14-0.68-2.130.990.240.070.332.0713.09N/A0.24
Long-term Debt to Capitalization
N/A0.72-0.004.380.380.180.030.220.610.44N/A0.18
Total Debt to Capitalization
N/A0.80-2.131.880.490.190.060.240.670.92N/A0.19
Interest Coverage Ratio
-344.60-1.05-6.742.41-1.65-1.00-60.59N/AN/AN/A-13.25-1.00
Cash Flow to Debt Ratio
N/A-1.08-1.680.250.320.14-3.52-2.05-0.96-0.29N/A0.14
Company Equity Multiplier
1.827.59-0.29-1.972.631.341.121.524.8623.101.251.34
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.71-0.24-0.520.050.070.01-0.12-0.25-0.13-0.25-1.670.01
Free Cash Flow / Operating Cash Flow Ratio
11110.940.411.011.001.2910.980.94
Cash Flow Coverage Ratio
N/A-1.08-1.680.250.320.14-3.52-2.05-0.96-0.29N/A0.14
Short Term Coverage Ratio
N/A-3.01-1.700.650.851.62-6.21-14.37-4.19-0.31N/A1.62
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-49.66%N/A